These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24296032)

  • 1. Nuclear PI-PLCβ1: an appraisal on targets and pathology.
    Follo MY; Faenza I; Piazzi M; Blalock WL; Manzoli L; McCubrey JA; Cocco L
    Adv Biol Regul; 2014 Jan; 54():2-11. PubMed ID: 24296032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear inositide specific phospholipase C signalling - interactions and activity.
    Faenza I; Fiume R; Piazzi M; Colantoni A; Cocco L
    FEBS J; 2013 Dec; 280(24):6311-21. PubMed ID: 23890371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New frontiers of inositide-specific phospholipase C in nuclear signalling.
    Cocco L; Maraldi NM; Manzoli FA
    Eur J Histochem; 2004; 48(1):83-8. PubMed ID: 15145779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Inositide Signaling Via Phospholipase C.
    Ratti S; Mongiorgi S; Ramazzotti G; Follo MY; Mariani GA; Suh PG; McCubrey JA; Cocco L; Manzoli L
    J Cell Biochem; 2017 Aug; 118(8):1969-1978. PubMed ID: 28106288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology.
    Cocco L; Faenza I; Follo MY; Billi AM; Ramazzotti G; Papa V; Martelli AM; Manzoli L
    Adv Enzyme Regul; 2009; 49(1):2-10. PubMed ID: 19159640
    [No Abstract]   [Full Text] [Related]  

  • 6. Nuclear phosphoinositides: location, regulation and function.
    Fiume R; Keune WJ; Faenza I; Bultsma Y; Ramazzotti G; Jones DR; Martelli AM; Somner L; Follo MY; Divecha N; Cocco L
    Subcell Biochem; 2012; 59():335-61. PubMed ID: 22374096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
    Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
    Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiology and pathology of nuclear phospholipase C β1.
    Cocco L; Follo MY; Faenza I; Fiume R; Ramazzotti G; Weber G; Martelli AM; Manzoli FA
    Adv Enzyme Regul; 2011; 51(1):2-12. PubMed ID: 21035488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide-specific phospholipase C beta1 signal transduction in the nucleus.
    Fiume R; Teti G; Faenza I; Cocco L
    Methods Mol Biol; 2010; 645():143-64. PubMed ID: 20645187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment.
    Follo MY; Russo D; Finelli C; Mongiorgi S; Clissa C; Filì C; Colombi C; Gobbi M; Manzoli L; Piazzi M; Martelli AM; Cocco L
    Leukemia; 2012 May; 26(5):943-50. PubMed ID: 22033492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear inositide signaling in myelodysplastic syndromes.
    Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
    J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear inositides: facts and perspectives.
    Martelli AM; Manzoli L; Cocco L
    Pharmacol Ther; 2004 Jan; 101(1):47-64. PubMed ID: 14729392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigenetics.
    Follo MY; Mongiorgi S; Finelli C; Piazzi M; Faenza I; Ramazzotti G; Santi P; McCubrey JA; Martelli AM; Cocco L
    Curr Pharm Des; 2012; 18(13):1751-4. PubMed ID: 22352752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling.
    Cocco L; Faenza I; Fiume R; Maria Billi A; Gilmour RS; Manzoli FA
    Biochim Biophys Acta; 2006; 1761(5-6):509-21. PubMed ID: 16624616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation.
    Faenza I; Billi AM; Follo MY; Fiume R; Martelli AM; Cocco L; Manzoli L
    Anticancer Res; 2005; 25(3B):2039-41. PubMed ID: 16158942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS.
    Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L
    Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear phospholipase C beta1 and cellular differentiation.
    Faenza I; Bregoli L; Ramazzotti G; Gaboardi G; Follo MY; Mongiorgi S; Billi AM; Manzoli L; Martelli AM; Cocco L
    Front Biosci; 2008 Jan; 13():2452-63. PubMed ID: 17981726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositide signaling in the nucleus: from physiology to pathology.
    Cocco L; Follo MY; Faenza I; Billi AM; Ramazzotti G; Martelli AM; Manzoli L; Weber G
    Adv Enzyme Regul; 2010; 50(1):2-11. PubMed ID: 19895834
    [No Abstract]   [Full Text] [Related]  

  • 19. Nuclear phospholipase C: a novel aspect of phosphoinositide signalling.
    Manzoli L; Billi AM; Faenza I; Matteucci A; Martelli AM; Peruzzi D; Falconi M; Rhee SG; Gilmour RS; Cocco L
    Anticancer Res; 1999; 19(5A):3753-6. PubMed ID: 10625953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear localization and signalling activity of inositol lipids.
    Cocco L; Maraldi NM; Capitani S; Martelli AM; Manzoli FA
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):31-43. PubMed ID: 11729971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.